HeartSciences Inc. HSCS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.53% | -100.00% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.53% | -100.00% | -- | -- | -- |
| Cost of Revenue | 0.00% | -100.00% | -- | -- | -- |
| Gross Profit | 18.18% | -100.00% | -- | -- | -- |
| SG&A Expenses | 131.61% | 107.31% | -3.59% | 71.45% | 3.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.78% | 31.78% | -18.66% | 4.57% | -9.62% |
| Operating Income | -56.83% | -32.08% | 18.66% | -4.45% | 9.71% |
| Income Before Tax | -54.37% | -31.35% | 21.73% | -12.86% | -0.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.37% | -31.35% | 21.73% | -12.86% | -0.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.37% | -31.35% | 21.73% | -12.86% | -0.16% |
| EBIT | -56.83% | -32.08% | 18.66% | -4.45% | 9.71% |
| EBITDA | -57.09% | -32.24% | 18.75% | -4.74% | 9.54% |
| EPS Basic | 45.16% | 55.23% | 75.59% | 62.76% | 40.24% |
| Normalized Basic EPS | 45.15% | 55.23% | 75.59% | 62.76% | 40.24% |
| EPS Diluted | 45.16% | 55.23% | 75.59% | 62.76% | 40.24% |
| Normalized Diluted EPS | 45.15% | 55.23% | 75.59% | 62.76% | 40.24% |
| Average Basic Shares Outstanding | 181.47% | 193.38% | 220.69% | 203.08% | 67.61% |
| Average Diluted Shares Outstanding | 181.47% | 193.38% | 220.69% | 203.08% | 67.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |